Enhancing Quality of Life for Breast Cancer Patients with Bone Metastases
Annual summary rept. 15 Mar 2007-14 Mar 2008
SYRACUSE UNIV RESEARCH FOUNDATION NY
Pagination or Media Count:
Current treatment for osteolytic breast cancer bone metastasis typically involves radiation therapy RTX to palliate bone pain and a bisphosphonate to inhibit osteoclastic bone resorption. The goal of this research was to determine the effects of zoledronic acid as an adjunct to RTX on restoring bone strength and density. We also investigated whether the combination of ZA and an anabolic agent parathyroid hormone, PTH as adjuncts to RTX further enhanced bone strength and thus decrease the risk of subsequent pathological fractures.
- Anatomy and Physiology
- Medicine and Medical Research